Published in PLoS One on September 21, 2016
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol (2002) 8.79
Differential antigen processing by dendritic cell subsets in vivo. Science (2007) 8.42
CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med (2000) 7.46
Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol (2006) 6.62
Cytochrome C-mediated apoptosis. Annu Rev Biochem (2004) 5.38
Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol (2001) 5.15
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med (1996) 4.70
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol (2003) 4.56
Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol (2006) 4.53
CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol (2000) 4.41
Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev (1997) 4.41
Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev (2004) 3.98
Cross-presentation by dendritic cells. Nat Rev Immunol (2012) 3.95
Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol (2008) 3.70
Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol (2005) 3.47
Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol (2001) 3.39
The CD8+ dendritic cell subset. Immunol Rev (2010) 3.32
Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science (2007) 3.27
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest (1983) 3.23
Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol (2008) 3.08
Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol (2001) 3.05
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett (2008) 2.85
The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood (2008) 2.83
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol (2014) 2.82
Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med (2012) 2.74
Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant (2003) 2.69
Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature (2006) 2.64
Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol (2007) 2.43
Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells. Immunity (2009) 2.17
TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol (2007) 2.15
The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation. J Immunol (2006) 2.09
Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity (2011) 1.96
Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule. J Biol Chem (2005) 1.90
The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity (2012) 1.89
Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem (2004) 1.79
Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J Immunol (2002) 1.76
Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology (2002) 1.72
Neutrophils efficiently cross-prime naive T cells in vivo. Blood (2007) 1.67
Demystifying the development of dendritic cell subtypes, a little. Immunol Cell Biol (2008) 1.60
Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc Natl Acad Sci U S A (2008) 1.53
Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proc Natl Acad Sci U S A (2009) 1.46
Specialized role of migratory dendritic cells in peripheral tolerance induction. J Clin Invest (2013) 1.33
Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2. J Immunol (2006) 1.31
Cytoskeleton in motion: the dynamics of keratin intermediate filaments in epithelia. J Cell Biol (2011) 1.25
Antigen delivery via two molecules on the CD8- dendritic cell subset induces humoral immunity in the absence of conventional "danger". Eur J Immunol (2005) 1.23
ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma. PLoS One (2012) 1.21
The CD300 molecules: an emerging family of regulators of the immune system. Blood (2013) 1.20
Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex. Immunogenetics (2004) 1.19
A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing. J Leukoc Biol (2006) 1.18
Differential effect of CD8(+) and CD8(-) dendritic cells in the stimulation of secondary CD4(+) T cells. Int Immunol (2001) 1.15
Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3. J Biol Chem (2007) 1.12
CD8alpha+ dendritic cells originate from the CD8alpha- dendritic cell subset by a maturation process involving CD8alpha, DEC-205, and CD24 up-regulation. Blood (2002) 1.11
Molecular cloning of a C-type lectin superfamily protein differentially expressed by CD8alpha(-) splenic dendritic cells. Mol Immunol (2001) 1.06
BTLA: a new inhibitory receptor with a B7-like ligand. Trends Immunol (2003) 1.04
Splenic stromal niches support hematopoiesis of dendritic-like cells from precursors in bone marrow and spleen. Exp Hematol (2009) 1.03
EMR4, a novel epidermal growth factor (EGF)-TM7 molecule up-regulated in activated mouse macrophages, binds to a putative cellular ligand on B lymphoma cell line A20. J Biol Chem (2002) 1.02
Cross-talk between the endocytic pathway and the endoplasmic reticulum in cross-presentation by MHC class I molecules. Curr Opin Immunol (2006) 1.00
Identification of a novel antigen cross-presenting cell type in spleen. J Cell Mol Med (2010) 0.98
Delineation of precursors in murine spleen that develop in contact with splenic endothelium to give novel dendritic-like cells. Blood (2010) 0.94
The Role of XCR1 and its Ligand XCL1 in Antigen Cross-Presentation by Murine and Human Dendritic Cells. Front Immunol (2012) 0.92
Molecular cloning of F4/80-like-receptor, a seven-span membrane protein expressed differentially by dendritic cell and monocyte-macrophage subpopulations. J Immunol (2001) 0.88
Steady-state cross-presentation of OVA is mannose receptor-dependent but inhibitable by collagen fragments. Proc Natl Acad Sci U S A (2010) 0.87
Ly49B is expressed on multiple subpopulations of myeloid cells. J Immunol (2006) 0.86
LILRA5 is expressed by synovial tissue macrophages in rheumatoid arthritis, selectively induces pro-inflammatory cytokines and IL-10 and is regulated by TNF-alpha, IL-10 and IFN-gamma. Eur J Immunol (2008) 0.86
Smad anchor for receptor activation (SARA) in TGF-beta signaling. Front Biosci (Elite Ed) (2010) 0.86
Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors. J Biol Chem (2012) 0.84
Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability. Exp Hematol (2012) 0.83
Novel splenic antigen-presenting cells derive from a Lin(-) c-kit(lo) progenitor. J Leukoc Biol (2012) 0.83
Development of two distinct dendritic-like APCs in the context of splenic stroma. Front Immunol (2013) 0.80
Immunotherapeutic potential of dendritic cells generated in long-term stroma-dependent cultures. Cancer Biother Radiopharm (1999) 0.80
CD300 molecule regulation of human dendritic cell functions. Immunol Lett (2012) 0.80
Characterisation of dendritic cells arising from progenitors endogenous to murine spleen. PLoS One (2014) 0.79
Distinct In Vitro Myelopoiesis is Dependent on the Self-Renewal of Hematopoietic Progenitors. Scand J Immunol (2012) 0.78
Distinct progenitor origin distinguishes a lineage of dendritic-like cells in spleen. Front Immunol (2014) 0.77
Investigation into the prevalence of a novel dendritic-like cell subset in vivo. J Cell Mol Med (2013) 0.76
The role of CD11b in phagocytosis and dendritic cell development. Immunol Lett (2008) 0.76
Redefining Myeloid Cell Subsets in Murine Spleen. Front Immunol (2016) 0.76
Antigen presenting capacity of murine splenic myeloid cells. BMC Immunol (2017) 0.75